| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |